OmniAb (OABI) Current Leases (2021 - 2026)
OmniAb (OABI) posted quarterly Current Leases of $3.9 million for Q1 2026, up 3.33% year-over-year from $3.8 million in Q1 2025, and up 1.57% quarter-over-quarter from $3.9 million in Q4 2025.
OmniAb (OABI) Current Leases (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Current Leases for 6 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 3.33% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (up 3.33% YoY), while the FY2025 annual figure was $3.9 million, up 2.56% from the prior year.
- Current Leases rose to $3.9 million in Q1 2026 per OABI's latest filing, from $3.9 million in the prior quarter.
- Across five years, Current Leases topped out at $3.9 million in Q1 2026 and bottomed at $1.8 million in Q4 2022.
- Historically, Current Leases has averaged $3.5 million across 5 years, with a median of $3.7 million in 2024.
- Annual changes were most pronounced in 2022 — Current Leases surged 207.96% — and 2025, when it grew 2.56%.
- OmniAb's Current Leases stood at $1.8 million in 2022, then surged by 95.84% to $3.5 million in 2023, then rose by 8.49% to $3.8 million in 2024, then gained by 2.56% to $3.9 million in 2025, then grew by 1.57% to $3.9 million in 2026.
- Business Quant data shows OABI's Current Leases at $3.9 million in Q1 2026, $3.9 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.97 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.88 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Mar 31, 2025 | 3.81 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 3.45 Mn |
| Jun 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 578,000.00 |